Miriam Barbieri - Publications

Sex- and age-dependent differences in detrimental repolarization-prolonging effects of doxorubicin: Evidence of cardiac toxicity beyond heart failure.

Journal: The Journal of physiology

Published: February 19, 2026

SGK1-inhibition restores cardiac repolarization in LQT2 rabbits and LQT3 mice by reducing late sodium current.

Journal: Pharmacological research

Published: February 16, 2026

Mechano-electrical feedback in transgenic rabbit models of long QT syndrome Type 2 and short QT syndrome Type 1.

Journal: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology

Published: September 03, 2025

Mechano-Electrical Feedback in Transgenic Rabbit Models of Long QT Syndrome Type 2 and Short QT Syndrome Type 1.

Journal: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology

Published: September 03, 2025

Current and future precision therapy approaches in the long QT syndrome.

Journal: Medizinische Genetik : Mitteilungsblatt des Berufsverbandes Medizinische Genetik e.V

Published: July 21, 2025

Beneficial action potential duration-shortening effects, but deleterious negative inotropism of IKs-activator docosahexaenoyl glycine in long QT syndrome type 2.

Journal: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology

Published: April 10, 2025

AAV9-mediated KCNH2 suppression-replacement gene therapy in a transgenic rabbit model of type 1 short QT syndrome.

Journal: European heart journal

Published: February 21, 2025

Sex and sex hormonal regulation of the atrial inward rectifier potassium current (IK1): insights into potential pro-arrhythmic mechanisms.

Journal: Cardiovascular research

Published: October 09, 2024

Therapeutic Efficacy of Mexiletine for Long QT Syndrome Type 2: Evidence From Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes, Transgenic Rabbits, and Patients.

Journal: Circulation

Published: June 28, 2024

KCNQ1 suppression-replacement gene therapy in transgenic rabbits with type 1 long QT syndrome.

Journal: European heart journal

Published: January 24, 2024

Simultaneous assessment of mechanical and electrical function in Langendorff-perfused ex-vivo mouse hearts.

Journal: Frontiers in cardiovascular medicine

Published: September 12, 2023

Gene- and variant-specific efficacy of serum/glucocorticoid-regulated kinase 1 inhibition in long QT syndrome types 1 and 2.

Journal: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology

Published: February 18, 2023